1. Home
  2. TPCS vs ANEB Comparison

TPCS vs ANEB Comparison

Compare TPCS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • ANEB
  • Stock Information
  • Founded
  • TPCS 1956
  • ANEB 2020
  • Country
  • TPCS United States
  • ANEB United States
  • Employees
  • TPCS N/A
  • ANEB N/A
  • Industry
  • TPCS Metal Fabrications
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • ANEB Health Care
  • Exchange
  • TPCS Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • TPCS 51.4M
  • ANEB 111.8M
  • IPO Year
  • TPCS N/A
  • ANEB 2021
  • Fundamental
  • Price
  • TPCS $5.12
  • ANEB $2.75
  • Analyst Decision
  • TPCS
  • ANEB Buy
  • Analyst Count
  • TPCS 0
  • ANEB 2
  • Target Price
  • TPCS N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • TPCS 30.2K
  • ANEB 25.4K
  • Earning Date
  • TPCS 08-21-2025
  • ANEB 11-12-2025
  • Dividend Yield
  • TPCS N/A
  • ANEB N/A
  • EPS Growth
  • TPCS N/A
  • ANEB N/A
  • EPS
  • TPCS N/A
  • ANEB N/A
  • Revenue
  • TPCS $33,424,000.00
  • ANEB N/A
  • Revenue This Year
  • TPCS N/A
  • ANEB N/A
  • Revenue Next Year
  • TPCS N/A
  • ANEB N/A
  • P/E Ratio
  • TPCS N/A
  • ANEB N/A
  • Revenue Growth
  • TPCS 3.78
  • ANEB N/A
  • 52 Week Low
  • TPCS $2.05
  • ANEB $0.80
  • 52 Week High
  • TPCS $6.25
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 46.78
  • ANEB 62.06
  • Support Level
  • TPCS $4.60
  • ANEB $2.50
  • Resistance Level
  • TPCS $5.41
  • ANEB $2.76
  • Average True Range (ATR)
  • TPCS 0.30
  • ANEB 0.13
  • MACD
  • TPCS -0.05
  • ANEB 0.04
  • Stochastic Oscillator
  • TPCS 38.44
  • ANEB 79.03

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: